Home

Procter & Gamble Health Ltd PE Ratio

Image

Procter & Gamble Health Ltd

NSE: PGHL

PE

35.8

Last updated on: Apr 04, 2025

Key Highlights

  • The P/E Ratio of Procter & Gamble Health Ltd is 35.8 as of 04 Apr 13:55 PM .
  • The p/e ratio of Procter & Gamble Health Ltd changed from 39.9 to 41.7 over 5 quarters. This represents a CAGR of 3.59% .
  • The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5239 as of 04 Apr 13:47 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Procter & Gamble Health Ltd

No data available

Company Fundamentals for Procter & Gamble Health Ltd

Image

Procter & Gamble Health Ltd

NSE: PGHL

Share Price

₹ 5239.55

-56.25 (-1.06%)

stock direction

Last updated on: Apr 04, 2025

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 20255295.8
02 Apr 20255259.35
01 Apr 20255152.3
28 Mar 20255142.3
27 Mar 20254997.4
26 Mar 20255320.85
25 Mar 20255410
24 Mar 20255470.85
21 Mar 20255486.15
20 Mar 20255333

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Procter & Gamble Health Ltd

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Procter & Gamble Health Ltd8790
Sun Pharmaceutical Industries Ltd424706
Divis Laboratories Ltd152946
Cipla Ltd120751
Torrent Pharmaceuticals Ltd109983
Mankind Pharma Ltd100168

PE Ratio of Procter & Gamble Health Ltd Explained

8790

Market cap

236

Earnings

35.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Procter & Gamble Health Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Procter & Gamble Health Ltd

No data available

* All values are in %

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
  • The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
  • They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
  • The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.

Procter & Gamble Health Ltd News Hub

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c

Read more

22 Aug 24

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on

Read more

21 Aug 24

Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by

Read more

21 Aug 24

Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the

Read more

22 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Procter & Gamble Health Ltd

What is the current PE Ratio of Procter & Gamble Health Ltd?

The Current PE Ratio of Procter & Gamble Health Ltd is 35.81 as on 4 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 4 Apr 2025.

What was the PE Ratio of Procter & Gamble Health Ltd last year?

The PE Ratio of Procter & Gamble Health Ltd was 37.97 last year, now the PE ratio is 35.81, showing a year-on-year growth of -5.7%.

What does the PE Ratio of Procter & Gamble Health Ltd indicate about its stock?

The PE Ratio of Procter & Gamble Health Ltd is 35.81. This ratio indicates that investors are willing to pay 35.81 times the earnings per share for each share of Procter & Gamble Health Ltd.

What is the PE Ratio Growth of Procter & Gamble Health Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Procter & Gamble Health Ltd grew by -5.7% whereas, the EPS ratio grew by 10.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions